Zdrowie i gospodarka · 14/06/2019

FDA Releases Draft Guidance on Biotin Interference Testing in In Vitro Diagnostic Devices

The Food and Drug Administration (FDA) has released a draft guidance document outlining its recommendations for testing biotin interference in in vitro diagnostic devices. The document aims to help device developers and clinicians understand how to perform and communicate the results of biotin interference testing.